Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.45% |
| 2 | Technology | 8.65% |
| 3 | Financials | 8.6% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WNS
651
DELISTED
WNS Holdings
WNS
| $27.3M | 0.03% |
412,907
+19,537
| +5% | +$1.22M |
|
652
Cytokinetics
CYTK
$10.9B
| $27.3M | 0.03% |
2,571,557
+578,539
| +29% | +$5.94M |
|
653
Blackrock
BLK
$181B
| $27.2M | 0.03% |
54,143
-46,440
| -46% | -$22M |
|
|
EPAY
654
DELISTED
Bottomline Technologies Inc
EPAY
| $27.2M | 0.03% |
507,398
+272,561
| +116% | +$12.4M |
|
655
Sea Limited
SE
$72.3B
| $27.2M | 0.03% |
675,752
-2,431
| -0.4% | -$81.8K |
|
656
First Bancorp
FBP
$4.29B
| $27.2M | 0.03% |
2,566,141
-1,827,950
| -42% | -$19.1M |
|
657
VeriSign
VRSN
$26.2B
| $27.2M | 0.03% |
141,000
-98,248
| -41% | -$18.5M |
|
658
NetEase
NTES
$81.7B
| $27.1M | 0.03% |
441,200
+188,325
| +74% | +$11M |
|
659
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $27M | 0.03% |
294,823
+49,338
| +20% | +$4.51M |
|
660
Rollins
ROL
$17.6B
| $26.9M | 0.03% |
1,218,926
+878,192
| +258% | +$20.8M |
|
|
RP
661
DELISTED
RealPage, Inc.
RP
| $26.9M | 0.03% |
501,205
+383,166
| +325% | +$21.8M |
|
662
Roku
ROKU
$23.5B
| $26.9M | 0.03% |
+201,078
| New | +$27.6M |
|
663
VEON
VEON
$4.23B
| $26.9M | 0.03% |
425,195
+412,084
| +3,143% | +$25.3M |
|
|
TVTY
664
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $26.9M | 0.03% |
1,321,765
+1,166,311
| +750% | +$21.8M |
|
|
CNST
665
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $26.8M | 0.03% |
+568,799
| New | +$16.4M |
|
|
PACK.WS
666
CALL
DELISTED
One Madison Corporation Warrants, each whole warrant is exercisable for one Class A Common Stock at
PACK.WS
| $26.8M | 0.03% |
+2,475,000
| New | +$1.84M |
|
667
PUT
NXP Semiconductors
NXPI
$56.1B
| $26.8M | 0.03% |
+210,400
| New | +$24.4M |
|
|
AGN
668
PUT
DELISTED
Allergan plc
AGN
| $26.8M | 0.03% |
140,000
-35,000
| -20% | -$6.31M |
|
669
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.68B
| $26.8M | 0.03% |
244,232
+165,130
| +209% | +$17.9M |
|
670
PUT
Akamai
AKAM
$15.2B
| $26.5M | 0.03% |
307,000
+275,400
| +872% | +$24.1M |
|
|
TPH
671
DELISTED
Tri Pointe Homes
TPH
| $26.5M | 0.03% |
1,701,189
-8,644
| -0.5% | -$133K |
|
672
Qualys
QLYS
$6.06B
| $26.5M | 0.03% |
317,522
+102,708
| +48% | +$8.52M |
|
673
PUT
Dollar General
DG
$27B
| $26.4M | 0.03% |
169,300
+164,300
| +3,286% | +$26.1M |
|
674
Steel Dynamics
STLD
$33.1B
| $26.2M | 0.03% |
770,279
-324,862
| -30% | -$10.4M |
|
|
SWAV
675
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $26.2M | 0.03% |
595,855
+453,000
| +317% | +$16.7M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.